| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Executive Officer | Director +1 more
2 companies
Grant Pickering is Chief Executive Officer at PCVX and has filed Form 4s across 2 companies. From December 2020 to September 2026, the filings on record show 1 open-market purchase and 57 sales. Grant Pickering's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $26.2M at current prices.
Historically, Grant Pickering's trades have earned a middling insider score of 50/100 across 63 rated trades. Over a 12-month horizon, 38.3% of those trades were profitable, with an average 12-month return of -21.8%.
The biggest single holding is PCVX (~$26.1M) as Chief Executive Officer. The PCVX filings lean toward selling, a net 740,510 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sell10b5-1 | 2,616 | $78.79 | $206,122.49 | -1.8% | +35.0% | -58.0% | |
| Jul 23, 2024 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 15,000 | $84.26 | $1,263,911.68 | -3.0% | +37.5% | -56.6% | |
| Jul 1, 2024 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sell10b5-1 | 2,616 | $76.33 | $199,689.86 | -1.8% | +48.5% | -57.2% | |
| Jun 24, 2024 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 15,000 | $75.64 | $1,134,579.44 | -3.0% | +47.9% | -55.0% | |
| Jun 3, 2024 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sell10b5-1 | 2,616 | $72.06 | $188,511.91 | -1.8% | +52.5% | -52.0% | |
| May 23, 2024 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 15,000 | $69.43 | $1,041,407.63 | -3.0% | +15.2% | -53.0% | |
| May 1, 2024 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sell10b5-1 | 2,616 | $61.70 | $161,419.23 | -1.8% | +25.4% | -44.7% | |
| Apr 23, 2024 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 15,000 | $61.92 | $928,845.00 | -3.0% | +38.1% | -45.5% | |
| Apr 1, 2024 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sell10b5-1 | 2,616 | $66.71 | $174,501.51 | -1.7% | +15.3% | -51.7% | |
| Mar 25, 2024 | PCVX Vaxcyte, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 15,000 | $66.93 | $1,003,978.40 | -3.0% | +14.2% | +8.3% |